Search
Denali Therapeutics Inc
DNLIAdd to Watchlist
24.040USD
+0.470+1.99%
Close 07-28 16:00（ET）Quotes delayed by 15 min
3.81BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-27The current institutional shareholding score of Denali Therapeutics Inc is 10.00, ranking 1 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 100.01%, representing a quarter-over-quarter decrease of 4.50%. The largest institutional shareholder is ETHSX, holding a total of 390.90K shares, representing 0.26% of shares outstanding, with 1.00% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Biogen Inc
Temasek Holdings Pte. Ltd.
State Street Investment Management (US)
Norges Bank Investment Management (NBIM)
Fidelity Management & Research Company LLC
1
2